{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:16:59Z","timestamp":1783477019321,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2019-I2M-5-020"],"award-info":[{"award-number":["2019-I2M-5-020"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204546"],"award-info":[{"award-number":["82204546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372194"],"award-info":[{"award-number":["82372194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["24JCYBJC01840"],"award-info":[{"award-number":["24JCYBJC01840"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["TJWJ2023QN034"],"award-info":[{"award-number":["TJWJ2023QN034"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["24ZYCGSY00640"],"award-info":[{"award-number":["24ZYCGSY00640"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["24ZXZSSS00480"],"award-info":[{"award-number":["24ZXZSSS00480"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.isci.2025.114136","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:17:03Z","timestamp":1763659023000},"page":"114136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering cantharidin\u2019s mechanism for cholangiocarcinoma treatment using patient-derived tumor organoids"],"prefix":"10.1016","volume":"28","author":[{"given":"Pinsheng","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhenZhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-2901","authenticated-orcid":false,"given":"Yamin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.114136_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","article-title":"Pathogenesis of Cholangiocarcinoma","volume":"16","author":"Rodrigues","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.isci.2025.114136_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2022.11.005","article-title":"Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma","volume":"78","author":"Merters","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.isci.2025.114136_bib3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.114136_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/toxins11040234","article-title":"Antiparasitic Properties of Cantharidin and the Blister Beetle Berberomeloe majalis (Coleoptera: Meloidae)","volume":"11","author":"Whitman","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.isci.2025.114136_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25143279","article-title":"Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways","volume":"25","author":"Naz","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2025.114136_bib6","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2174\/0929867330666221103151537","article-title":"Exploring Cantharidin and its Analogues as Anticancer Agents: A Review","volume":"30","author":"Li","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.isci.2025.114136_bib7","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3892\/or.2016.4684","article-title":"Cantharidin inhibits cell proliferation and induces apoptosis through G2\/M phase cell cycle arrest in hepatocellular carcinoma stem cells","volume":"35","author":"Le","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.isci.2025.114136_bib8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41389-018-0102-2","article-title":"The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer","volume":"7","author":"Xu","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.isci.2025.114136_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.108939","article-title":"Cantharidin suppresses gastric cancer cell migration\/invasion by inhibiting the PI3K\/Akt signaling pathway via CCAT1","volume":"317","author":"Song","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.isci.2025.114136_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/ijms24021179","article-title":"Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis-Inducing Genes S100A4 and MACC1","volume":"24","author":"Sch\u00f6pe","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.114136_bib11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1159\/000484069","article-title":"Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo","volume":"43","author":"Li","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.isci.2025.114136_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s12272-013-0044-3","article-title":"Anti-metastatic effect of cantharidin in A549 human lung cancer cells","volume":"36","author":"Kim","year":"2013","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.isci.2025.114136_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107668","article-title":"Tumor organoid models in precision medicine and investigating cancer-stromal interactions","volume":"218","author":"Xu","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2025.114136_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2025.114136_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0040-1719176","article-title":"Organoids for the Study of Liver Cancer","volume":"41","author":"Wang","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.isci.2025.114136_bib16","article-title":"Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions","volume":"5","author":"Zhu","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.114136_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","article-title":"Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.114136_bib18","article-title":"Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application","volume":"4","author":"Ren","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.114136_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2025.114136_bib20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2025.114136_bib21","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/tox.23826","article-title":"TRIM29 facilitates proliferation and malignancy of cholangiocarcinoma cells by activating MAPK and \u03b2-catenin pathways","volume":"38","author":"Yang","year":"2023","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.isci.2025.114136_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2021.10.014","article-title":"(125)I seeds inhibit proliferation and promote apoptosis in cholangiocarcinoma cells by regulating the AGR2-mediated p38 MAPK pathway","volume":"524","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2025.114136_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/cam4.1313","article-title":"Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling","volume":"7","author":"Peng","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.isci.2025.114136_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1080\/13880209.2023.2191645","article-title":"Isoalantolactone suppresses gallbladder cancer progression via inhibiting the ERK signalling pathway","volume":"61","author":"Lv","year":"2023","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.isci.2025.114136_bib25","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2431150","article-title":"TRPC6 knockdown-mediated ERK1\/2 inactivation alleviates podocyte injury in minimal change disease via upregulating Lon peptidase 1","volume":"46","author":"Ma","year":"2024","journal-title":"Ren. Fail."},{"key":"10.1016\/j.isci.2025.114136_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113669","article-title":"CAVIN2 attenuates ventilator-induced lung injury in rats by MAPK\/ERK1\/2 signaling pathway","volume":"144","author":"Zhu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2025.114136_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13287-024-03899-7","article-title":"SMYD1 modulates the proliferation of multipotent cardiac progenitor cells derived from human pluripotent stem cells during myocardial differentiation through GSK3\u03b2\/\u03b2-catenin&ERK signaling","volume":"15","author":"Chang","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.isci.2025.114136_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep11836","article-title":"Cantharidin represses invasion of pancreatic cancer cells through accelerated degradation of MMP2 mRNA","volume":"5","author":"Shen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.114136_bib29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1349-7006.2010.01523.x","article-title":"Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2\/M cell-cycle arrest and apoptosis","volume":"101","author":"Li","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.isci.2025.114136_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12906-023-03975-0","article-title":"Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2\/H3K27me3-dependent cell cycle progression and antitumour immune response","volume":"23","author":"Yan","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.isci.2025.114136_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.stem.2023.05.012","article-title":"Organoid cultures for cancer modeling","volume":"30","author":"Yan","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.isci.2025.114136_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.trecan.2021.12.004","article-title":"Modeling tumor plasticity in organoid models of human cancer","volume":"8","author":"Christin","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.isci.2025.114136_bib33","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.114136_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41467-023-35896-4","article-title":"Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114136_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121490","article-title":"Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2025.114136_bib36","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.celrep.2019.03.088","article-title":"Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma","volume":"27","author":"Saito","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.114136_bib37","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.7150\/ijbs.96317","article-title":"Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment","volume":"20","author":"Rao","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2025.114136_bib38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.114136_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153701","article-title":"Therapeutic Effect of Regional Chemotherapy in Diffuse Metastatic Cholangiocarcinoma","volume":"14","author":"Vashist","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2025.114136_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1201404","article-title":"Hepatotoxic mechanism of cantharidin: insights and strategies for therapeutic intervention","volume":"14","author":"Jin","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2025.114136_bib41","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2174\/0929867324666170414165253","article-title":"Overview of Cantharidin and its Analogues","volume":"25","author":"Wang","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.isci.2025.114136_bib42","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1074\/jbc.RA118.003890","article-title":"The natural anticancer agent cantharidin alters GPI-anchored protein sorting by targeting Cdc1-mediated remodeling in endoplasmic reticulum","volume":"294","author":"Sahu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.114136_bib43","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/j.fct.2008.06.084","article-title":"Liposome encapsulation reduces cantharidin toxicity","volume":"46","author":"Chang","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.isci.2025.114136_bib44","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3390\/ijms26031215","article-title":"Evaluation of a Norcantharidin Nanoemulsion Efficacy for Treating B16F1-Induced Melanoma in a Syngeneic Murine Model","volume":"26","author":"Mart\u00ednez-Razo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.114136_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2025.114136_bib46","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/cells8101172","article-title":"Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link","volume":"8","author":"Chen","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.isci.2025.114136_bib47","first-page":"7672","article-title":"Role of cantharidin in the activation of IKK\u03b1\/I\u03baB\u03b1\/NF-\u03baB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines","volume":"17","author":"Zhou","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.isci.2025.114136_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108156","article-title":"Organ-on-a-chip platforms as novel advancements for studying heterogeneity, metastasis, and drug efficacy in breast cancer","volume":"237","author":"Kalot","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2025.114136_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188717","article-title":"Organ-on-Chip platforms to study tumor evolution and chemosensitivity","volume":"1877","author":"Dsouza","year":"2022","journal-title":"Biochim. Biophys. Acta. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.114136_bib50","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.7150\/thno.87266","article-title":"Organ-on-a-chip meets artificial intelligence in drug evaluation","volume":"13","author":"Deng","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2025.114136_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104868","article-title":"Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2\/STAT3 and PI3K\/Akt pathways in an EphB4-dependent manner","volume":"158","author":"Zhu","year":"2020","journal-title":"Pharmacol. Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225023971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225023971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:42:23Z","timestamp":1783474943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225023971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2589004225023971"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.114136","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering cantharidin\u2019s mechanism for cholangiocarcinoma treatment using patient-derived tumor organoids","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.114136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114136"}}